Skip to main content
. 2022 May 14;1(5):882–893. doi: 10.1016/j.gastha.2022.05.006

Figure.

Figure

Common oxidative stress mechanism underlies hepatocellular damage by several exogenous and endogenous toxins. Merging clinical phenotypes of fatty liver disease (NAFLD/MAFLD, NASH, DILI, ALD) into a single basket entity, toxic liver diseases (TLDs), based on common pathomechanism will allow clinicians to evaluate the benefits of silymarin as an antioxidant and potential hepatoprotective agent.